Biliary Obstruction Clinical Trials

8 recruitingLast updated: May 21, 2026

There are 8 actively recruiting biliary obstruction clinical trials across 7 countries. Studies span Not Applicable, Phase 2. Top locations include Alicante, Valencia, Spain, Barcelona, Catalonia, Spain, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Biliary Obstruction Trials at a Glance

8 actively recruiting trials for biliary obstruction are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Alicante, Barcelona, and Barcelona. Lead sponsors running biliary obstruction studies include Hospital Universitari de Bellvitge, National Taiwan University Hospital, and Chinese University of Hong Kong.

Browse biliary obstruction trials by phase

About Biliary Obstruction Clinical Trials

Looking for clinical trials for Biliary Obstruction? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Biliary Obstruction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Biliary Obstruction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Prospective Registry Of Therapeutic EndoscopiC ulTrasound

Chronic PancreatitisGastric Outlet ObstructionAcute Pancreatic Fluid Collection+3 more
Paolo Giorgio Arcidiacono, MD510 enrolled1 locationNCT04813055
Recruiting
Not Applicable

EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent

Malignant Biliary Obstruction
Chinese University of Hong Kong20 enrolled1 locationNCT05169398
Recruiting
Phase 2

Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis

Biliary tract infectionCholedocholithiasisMalignant Biliary Stricture+2 more
National University of Malaysia172 enrolled1 locationNCT07407491
Recruiting
Not Applicable

Safety and Efficacy of Mechanical Versus Electrocautery Dilator for EUS-guided Biliary Drainage (MED-BD)

Biliary Obstruction
National Taiwan University Hospital64 enrolled1 locationNCT06620328
Recruiting

Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction

DiagnosisNon-invasive Diffusion-weighted ImagingMagnetic Resonance Cholangiopancreatography+1 more
The General Authority for Teaching Hospitals and Institutes100 enrolled1 locationNCT07108725
Recruiting
Not Applicable

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Pancreatic CancerBiliary Tract NeoplasmsMalignant Biliary Obstruction
Hospital Universitari de Bellvitge120 enrolled10 locationsNCT06653192
Recruiting
Not Applicable

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Biliary Tract NeoplasmsPancreatic Cancer Non-resectableMalignant Biliary Obstruction
Hospital Universitari de Bellvitge128 enrolled10 locationsNCT06375967
Recruiting
Not Applicable

Prevention of Acute Cholecystitis With ETGBD

Acute CholecystitisBiliary Obstruction
Seoul National University Hospital35 enrolled1 locationNCT06287112